• Register
  • Login
  • Subscribe
  • Contact Us

Placebo and Blinding Medications for the Needs of Non -Commercial Clinical Examination

PolandTenders notice for Placebo and Blinding Medications for the Needs of Non -Commercial Clinical Examination. The reference ID of the tender is 124801211 and it is closing on 28 Aug 2025.

Tender Details

  • Country: Poland
  • Summary: Placebo and Blinding Medications for the Needs of Non -Commercial Clinical Examination
  • PLT Ref No: 124801211
  • Deadline: 28 Aug 2025
  • Financier: Self Financed
  • Purchaser Ownership: Government
  • Tender Value: Refer Document
  • Notice Type: Tender
  • Document Ref. No.: CP-24-618-2/2025/ABM
  • Purchaser's Detail:
    Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
  • Description:
  • 1. The subject of this order is: manufacturing and providing placebo for a medicinal product (dapagliflozin) and blindness, repacking and labeling the medicinal product/placebo with their dismissal for use in non -commercial clinical trial and disposal of unused products - for the purposes of the implementation of non -commercial clinical trial entitled "Comparison of the effectiveness of patients with systemic scleroderma using the SGLT2 dapagliflosin inhibitor for treatment with tovizumab: Randomized Head-to-Head" randomized examination financed from the state budget, based on the state budget, based on the state budget Agreements No. 2023/ABM/021/00080-00.3. Another order is financed from the state budget, based on contract No. 2023/ABM/021/00080-00o co-financing of the project of non-commercial clinical trial, which obtained financing as part of a competition for non-commercial clinical examinations by the medical research agency. 4. The documentation of the procedure has been made available in the "Annex" tab. Instructions regarding the use of purchasing platform are available at: //cmkp.eb2b.com.pl/cms-directory.html/regulats.
    Record Number: AU-000266
  • Documents:

 Tender Notice

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

Placebo and Blinding Medications for the Needs of Non -Commercial Clinical Examination - Poland Tender

The POSTGRADUATE MEDICAL CENTER, a Government sector organization in Poland, has announced a new tender for Placebo and Blinding Medications for the Needs of Non -Commercial Clinical Examination. This tender is published on PolandTenders under PLT Ref No: 124801211 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2025-08-28.

The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.

PolandTenders Features

PolandTenders Features

Fresh and verified Tenders from Poland. Find, search and filter Tenders/Call for bids/RFIs/RFPs/RFQs/Auctions published by the government, public sector undertakings (PSUs) and private entities.

  • 1,000+ Tenders
  • Verified Tenders Only
  • New Tenders Every Day
  • Tenders Result Data
  • Archive & Historical Tenders Access
  • Consultants for RFI/RFP/RFQ
  • Tender Notifications & Alerts
  • Search, Sort, and Filter Tenders
  • Bidding Assistance & Consulting
  • Customer Support
  • Publish your Tenders
  • Export data to Excel
  • API for Tender Data
  • Tender Documents
Tender Experts

Get A Call From Tender Experts

Fill out the form below and you will receive a call from us within 24 hours.

Thank You for Contacting PolandTenders !!
Email Id is already exist !!
Captcha Image
Invalid Captcha !

Get FREE SAMPLE TENDERS from Poland in your email inbox.

  Chat with us